R
Robert F. Meenan
Researcher at University of Utah
Publications - 12
Citations - 1349
Robert F. Meenan is an academic researcher from University of Utah. The author has contributed to research in topics: Rheumatoid arthritis & Clinical trial. The author has an hindex of 10, co-authored 12 publications receiving 1335 citations. Previous affiliations of Robert F. Meenan include Boston Medical Center & American College of Rheumatology.
Papers
More filters
Journal ArticleDOI
Outcome assessment in clinical trials. Evidence for the sensitivity of a health status measure.
Robert F. Meenan,Jennifer J. Anderson,Lewis E. Kazis,Lewis E. Kazis,Marlene J. Egger,Mary Altz‐Smith,Mary Altz‐Smith,Cecil O. Samuelson,Robert F. Willkens,Robert F. Willkens,Marilyn A. Solsky,Marilyn A. Solsky,Stanley P. Hayes,Stanley P. Hayes,Kenneth L. Blocka,Kenneth L. Blocka,Arthur Weinstein,Arthur Weinstein,Maria Guttadauria,Maria Guttadauria,Stanley B. Kaplan,Stanley B. Kaplan,John H. Klippel,John H. Klippel +23 more
TL;DR: The performance of a self-administered health status questionnaire in a randomized, double-blind, 21-week comparison of placebo, oral gold, and injectable gold in rheumatoid arthritis patients is described.
Journal Article
The prevalence of chondrocalcinosis in the elderly and its association with knee osteoarthritis: the Framingham Study.
TL;DR: The results confirm that chondrocalcinosis is significantly associated with OA after controlling for age, but they also suggest that chondaureticcinosis and OA increase independently with age.
Journal ArticleDOI
Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial
John R. Ward,H. James Williams,Marlene J. Egger,James C. Reading,Eric G. Boyce,Mary Altz‐Smith,Cecil O. Samuelson,Robert F. Willkens,Marilyn A. Solsky,Stanley P. Hayes,Kenneth L. Blocka,Arthur Weinstein,Robert F. Meenan,Maria Guttadauria,Stanley B. Kaplan,John H. Klippel +15 more
TL;DR: Results confirm that both parenteral and oral gold may be effective for the treatment of RA, that GST tends to show greater efficacy than auranofin, and that auran ofin has fewer significant adverse effects than GST, however, long-term benefits, tolerability, and safety cannot be inferred.
Journal ArticleDOI
Which traditional measures should be used in rheumatoid arthritis clinical trials
Jennifer J. Anderson,Jennifer J. Anderson,David T. Felson,Robert F. Meenan,H. James Williams +4 more
TL;DR: An analysis of pooled raw data from 3 placebo-controlled RA trials shows that the joint tenderness count, erythrocyte sedimentation rate, grip strength, and physician assessment of disease activity perform best in RA clinical trials and cover the domain of change measured by traditional outcome measures.